Clinical Trials in Nashville

Showing 10661-10680 of 17,403 trials

Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

NCT02927223

To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.

Catecholaminergic Polymorphic Ventricular Tachycardia

Vanderbilt University6 participantsStarted Oct 2016

Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors

NCT02743637

This is a Phase 1 dose escalation to assess the safety, tolerability and maximum tolerated dose of subcutaneous administered SDX-7320 in patients with advanced refractory or late-stage solid tumors.

Advanced MalignancyAdvanced Solid TumorsNeoplasm+1 more

SynDevRx, Inc.32 participantsStarted Feb 2016

Scottsdale, Arizona, United States • Los Angeles, California, United States • Nashville, Tennessee, United States

COMPLETEDPhase 1< 1 mile

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

NCT02383212

This is a phase 1, open-label, multicenter, ascending-dose escalation study of cemiplimab, alone and in combination with other anti-cancer therapies in patients with advanced malignancies.

Advanced CancerAdvanced Malignancies

Regeneron Pharmaceuticals398 participantsStarted Feb 2015

Gilbert, Arizona, United States • Goodyear, Arizona, United States • Phoenix, Arizona, United States +44 more locations

Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Find Trials by Condition in Nashville

Vitamin D to Improve Outcomes by Leveraging Early Treatment

Dasotraline Pediatric Extension Study

Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

Severe ARDS: Generating Evidence

Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding

A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

Frozen Red Blood Cell Transfusions in Trauma Patients

A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8

A Study of Siltuximab (Anti- IL 6 Monoclonal Antibody) in Patients With High-risk Smoldering Multiple Myeloma

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia

First in Patient Study for PF-06840003 in Malignant Gliomas

Integrated Tele-monitoring and Patient-centric Health Coaching Strategy in Patients Hospitalized With Heart Failure

Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma